Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine.
about
Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and DevelopmentThe Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular DiseaseAging of the nitric oxide system: are we as old as our NO?Asymmetric dimethylarginine (ADMA), nitric oxide metabolite, and estradiol levels in serum and peritoneal fluid in women with endometriosis.Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).ADMA metabolism and clearance.How to control NO production in cells: N(omega),N(omega)-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target.Arginine, arginine analogs and nitric oxide production in chronic kidney disease.Endogenous inhibitors of nitric oxide and preeclampsia: a review.Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.Nitric oxide deficiency in chronic kidney disease.Sexual dimorphism: the aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity.Sexual dimorphism of the aging kidney: role of nitric oxide deficiency.Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort.The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.Cellular ADMA: regulation and action.Sexual dimorphism, the aging kidney, and involvement of nitric oxide deficiency.Renal biomarkers in domestic species.Plasma amino acid profiles are associated with biomarkers of breast cancer risk in premenopausal Japanese women.A relative L-arginine deficiency contributes to endothelial dysfunction across the stages of the menopausal transition.Vascular Aging: Implications for Cardiovascular Disease and Therapy.Vitamin D and methylarginines in chronic kidney disease (CKD)Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.MTHFR C677T polymorphism modifies the effect of HRT on metabolic parameters in postmenopausal women.Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects.Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study.Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol.Asymmetrical dimethylarginine levels on the implantation success of in vitro fertilization and embryo transfer.Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis.PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
P2860
Q28070134-37B6BFAF-A117-4C0E-AFF4-5C51B0C66C32Q33940891-2CC7C5BC-A011-4C54-A87B-9C99D0184031Q35026305-AE1BD584-38FA-4590-89C1-F5B98B112F0AQ35917599-3F17ACBC-CDFC-4F71-B394-2C782E089BC6Q36018553-3924AD4B-1381-4F09-9A04-F3919028EA21Q36381009-E4283B4D-299E-4324-9F8E-D3EDC22C3E19Q36381017-8F24FA82-8826-4C4E-B93C-661D5B231EE5Q36471209-E65830D3-281B-45B7-B568-698009E747ABQ36577145-40E1DAB5-CB58-483C-AEDD-C5F83D16B258Q36590924-10E4534C-5621-410C-B110-7A4A271A8CFBQ36602684-CEAE5778-755B-4871-B8FF-D1A039CBF5BAQ36967585-EE89746C-1BA2-43EB-BC39-963DEADCBE54Q37003151-9349E348-6936-41D1-82EB-DFFD6A4ADA53Q37192036-880DC3C5-58EA-460D-A70A-30DB5A07E999Q37224328-4B28878C-B098-4B9D-AF25-BEA5FCB8E8DBQ37313734-A477E579-7862-4B2E-A48D-A4D7BA402E8CQ37399711-A92C2969-5ACA-41A7-8284-7338D6D2CEB7Q37484915-8E307566-422D-4F1F-AE08-045208F28026Q38751246-87344378-DCB6-4D2C-B55E-3D98098B2382Q39321879-D1BA383E-AEDE-461A-92BE-B3BC55B39FC4Q41037479-15F13347-CEDD-42A2-A8F4-B1D4A559719DQ41728173-D8EF81AE-D7E0-4738-A3EC-188AEB0F081EQ42370194-B1336F7F-161F-4AD2-8B26-0A46657E505AQ44130303-A3FC1D1E-99DF-458A-88A1-A41187EF8D0CQ46565213-A9575848-180E-4D63-8295-38F2FE1177A6Q46716308-479E66AC-6150-4E93-B19D-3CD7256BF657Q46899634-41151849-1EBA-46AE-91AC-250346BCCF0EQ47107685-DA8A3D63-7FD8-4281-80E4-CF3B4BF1EE01Q48651344-6309E447-CA03-4A32-9CC1-CDB260821375Q52632609-ACFB83DB-84E3-44E2-86DF-F9F4DFD5FF38Q58699564-97160C3C-B764-4D76-9F33-002CAEEF88E3
P2860
Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Estrogen stimulates dimethylar ...... f asymmetric dimethylarginine.
@en
type
label
Estrogen stimulates dimethylar ...... f asymmetric dimethylarginine.
@en
prefLabel
Estrogen stimulates dimethylar ...... f asymmetric dimethylarginine.
@en
P2093
P1433
P1476
Estrogen stimulates dimethylar ...... f asymmetric dimethylarginine.
@en
P2093
Desmond P Holden
Guy St J Whitley
Stephen S Nussey
P304
P356
10.1161/01.CIR.0000091083.61609.DF
P407
P577
2003-09-08T00:00:00Z